Bausch Health Companies Inc.
General ticker "BHC" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.3B (TTM average)
Bausch Health Companies Inc. follows the US Stock Market performance with the rate: 1.5%.
Estimated limits based on current volatility of 2.4%: low 5.02$, high 5.28$
Factors to consider:
- Total employees count: 20700 as of 2024
- Top business risk factors: BL separation risks, Litigation risks, Economic downturns and volatility, Regulatory and compliance, Reputation and brand risks
- Current price 14.8% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.81$, 10.03$]
- 2026-12-31 to 2027-12-31 estimated range: [6.17$, 10.62$]
Financial Metrics affecting the BHC estimates:
- Positive: with PPE of 1.9 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 53.71 > 12.90
- Positive: 7.54 < Operating profit margin, % of 17.91
- Negative: negative Industry operating cash flow (median)
- Negative: Interest expense per share per price, % of 61.53 > 3.31
- Negative: negative Industry operating income (median)
- Positive: -3.75 < Return on assets ratio (scaled to [-100,100]) of 0.45
Short-term BHC quotes
Long-term BHC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $8,729.00MM | $9,378.00MM | $10,124.00MM |
| Operating Expenses | $7,766.00MM | $7,832.00MM | $8,311.00MM |
| Operating Income | $963.00MM | $1,546.00MM | $1,813.00MM |
| Non-Operating Income | $-1,353.00MM | $-1,379.00MM | $-1,446.00MM |
| Interest Expense | $1,328.00MM | $1,388.00MM | $1,604.00MM |
| R&D Expense | $604.00MM | $616.00MM | $629.00MM |
| Income(Loss) | $-390.00MM | $167.00MM | $367.00MM |
| Taxes | $221.00MM | $239.00MM | $247.00MM |
| Net Income(Loss)* | $-592.00MM | $-46.00MM | $157.00MM |
| Stockholders Equity | $-1,022.00MM | $-1,279.00MM | $-554.00MM |
| Inventory | $1,544.00MM | $1,595.00MM | $1,626.04MM |
| Assets | $27,350.00MM | $26,523.00MM | $26,366.00MM |
| Operating Cash Flow | $1,032.00MM | $1,597.00MM | $1,400.00MM |
| Capital expenditure | $272.00MM | $337.00MM | $397.00MM |
| Investing Cash Flow | $-2,145.00MM | $-454.00MM | $-595.00MM |
| Financing Cash Flow | $1,475.00MM | $-868.00MM | $-742.00MM |
| Earnings Per Share** | $-1.62 | $-0.12 | $0.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.